Second Sight Medical Products, Inc. (NASDAQ: EYES) today announced positive five-year outcomes associated with patients using the Argus® II Retinal ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE